Hodgkin’s Lymphoma Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 17
SKU : PH2084
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
How big is the Hodgkin’s Lymphoma Market ?
Global Hodgkin’s Lymphoma Market reached US$ 0.9 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 2.1 billion by 2031.
Who are the key players in Hodgkin’s Lymphoma Market ?
Major global players are Merck & Co., Inc., Bristol Myers Squibb, F. Hoffmann-La Roche Ltd, Seagen Inc., Ono Pharmaceutical Co., Ltd., AstraZeneca, Inc., Actinium Pharmaceuticals, Inc., Pfizer Inc., Affimed GmbH and Incyte.
Related Reports
pharmaceuticalsT-cell-lymphoma Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350
pharmaceuticalsDiffuse Large B-cell Lymphoma Therapeutics Market Size, Share, Value and Forecast (2024-2031)
Published: 2024 January 10
Starting from
$4350
pharmaceuticalsAcute Lymphocytic Leukemia Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 22
Starting from
$4350
pharmaceuticalsImmunotherapy Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 19
Starting from
$4350
pharmaceuticalsMantle Cell Lymphoma Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 January 17
Starting from
$4350
pharmaceuticalsNon-Hodgkin Lymphoma Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 23
Starting from
$4350